(877) 505-4777| info@speakersnetwork.com

Endocrinology, Diabetes & Metabolism

Chief, Endocrinology, Diabetes and Metabolism
Program Director for Endocrinology
Clinical Professor of Medicine

What type of Diabetes is it? Implications for management decisions in diabetes care
Diabetes Guidelines Update
Endocrine Disorders in Elder Patients
Management of Type 2 Diabetes
Outpatient Diabetes Management
Current Standards of Diabetes Care
New Diabetes Medications
Inpatient Management of Diabetes
Oral and Non-Insulin Therapies for Diabetes
How to Use Insulin
Diabetes Management in Long-Term Care Facilities
Oral and Non-Insulin therapies

She was awesome! – Providence Saint Joseph Medical Center She was a fantastic speaker, very well received, easy to follow and full of information. I give her an A+ – Providence Holy Cross Medical CenterÒBring her back!Ó – Providence Saint Joseph Medical Center
CA

Professor and Director
Division of Endocrinology, Diabetes and Metabolism
The University of Tennessee Health Science Center

Inpatient Glucose Control in Medical vs. Surgical ICU
Outpatient Management of Patients with Type II Diabetes
Metabolic Syndrome Pathogenesis and Treatment of with Polypills
Oxidative Stress and Pro Inflammatory State in Diabetes
Hyperglycemia Crisis New ADA and AACE Guidelines
Diabetes Prevention Programs
Strategic Approaches to Treatment of Type II Diabetes with the Use of Incretins

TN

Associate Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
Indiana University School of Medicine

Fats of Life: Arguing the Guidelines While Our Arteries Get Clogged
Type 2 DM Management Updates
Metabolic Syndrome: The Deadly Fashion of Today
NAFLD
Testosterone Replacement and Mens Health
Diabetic Feet: Getting a Foot Hold on Pathology and Tiptoeing to Management

IN

Professor of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology
Baylor College of Medicine

Global Cardiovascular Risk Reduction in the Patient with Diabetes
Diabetes
Dyslipidemias
Metabolic Syndrome
Atherosclerosis
Incretins: GLP-I and DPP-4

TX

Assistant Professor of Clinical Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Miami Miller School of Medicine

Male Hypogonadism: Low Testosterone
Appropriate Use of Growth Hormone
Adrenal Disease including Tumors
Thyroid Disease including Tumors
Obesity

Dr. Kargi obtained his medical degree in Izmir, Turkey. He completed internal medicine residency at the University of Pittsburgh and fellowship in endocrinology at the University of Washington in Seattle, WA. During his fellowship Dr. Kargi performed basic science research investigating the mechanisms linking inflammation with lipoprotein metabolism and atherosclerosis. In 2008 Dr. Kargi joined the faculty at the University of Miami, Miller School of Medicine in the clinical educator career track. He is coordinator of the medical school endocrine and reproductive systems course , director of the U.M.H. and Jackson Memorial inpatient endocrinology consultation service and co-director of University of Miami Endocrine Testing Center. Dr. Kargis clinical research interests include the diagnosis of growth hormone deficiency, treatment of male hypogonadism, and tumors of the adrenal and pituitary glands.
fl

Assistant Attending Physician
Memorial Sloan-Kettering Cancer Center
Joan & Sanford I. Weill Medical College of Cornell University

Chronic Kidney Disease
Mineral and Bone Disorder
Pituitary Apoplexy
Hypertension
Metabolic Bone Disease and Diabetes
Diabetes
Osteoporosis
Bone Metastases from Cancer
Treatment with Intravenous Bisphosphonates
Vitamin D and Bone Health
Thyroid Nodules
Primary Hyperparathyroidism
Obesity and Nutrition
Cancer Treatment Induced Bone Loss
Osteonecrosis of the Jaw
Secondary Hyperparathyroidism Due to Vitamin D Deficiency
Skeletal Related Events in Thyroid Cancer
Long and Short Term Complications of Bisphosphonate Therapy
Endocrine Causes of Hypertension
Non-pharmaceutical Management of Osteoporosis
Male Hypogonadism
Multiple Uses of Antiresorptives in Malignancy: Prevention of Pain, Bone Loss, and Skeletal Related Events
Review: National Comprehensive Cancer Network Guidelines on Cancer and Bone Disease
Pagets Disease of Bone, HPP, and Rare Causes of Bone Fragility

Dr. Farooki was EXCELLENT! ÊWe highly recommend him. The Guthrie Clinic
NY

Past Clinical Chief, Division of Endocrinology
Associate Clinical Professor of Endocrinology

How to Use the Newest Diabetes Treatments: The Incretin Concept
Intensive Blood Glucose Control for the Hospitalized Patient: A New Standard or Pie in the Sky?
Oral Agents in GDM
Diabetes Update
Pills for Diabetes: Old Choices, New Data
The Evolution of the Insulin Molecule and Insulin Treatment
What’s New about Preventing Diabetic Complications
Diabetic Ketoacidosis: Update in Concepts and Treatments
What Can Doctors Do about Obesity: Medical and Surgical Options
Diabesity: Combined Causes and Combined Risks
Breakthroughs in Obesity Concepts: Leptin, Ghrelin and PYY for the Treatment of Obesity
Thyroid Update
Hyperthyroidism in Primary Care: Diagnosis and Treatment
Hypothyroidism in Primary Care: Changing Concepts
How to Effectively Screen for Endocrine Disease in Primary Care Practice: From Addison’s to Acromegaly
Surgical Options for Obesity

“Excellent speaker and content…First lecture in 20 years that I had no idea what the subject was about and now I know!” – Northridge Hospital
CA

Professor of Medicine
Division of Endocrinology
Stanford University School of Medicine

Thyroid Disorders
Primary Hyperparathyroidsim
Vitamin D: Its Not Just for Bones Anymore
Hypercalcemia

CA

Director, Division of Development & Translational Diabetes and Endocrine Research
Chair and Professor, Department of Clinical Diabetes, Endocrinology and Metabolism
Professor, Department of Diabetes and Metabolic Diseases Research
City of Hope National Medical Center

Islet Transplantation
Current Concepts in the Use of Insulin in the Treatment of Diabetes

Dr. Fouad Kandeel is the Principal Investigator on the islet transplantation trial to determine the safety and efficacy of islet cell transplantation as a treatment for patients with type 1 diabetes. In addition, Dr. Kandeel has recently concluded a clinical project to identify genes related to the development of type 2 diabetes and cardiovascular disease in the Hispanic population. He also continues to oversee the Diabetes and Cardiovascular Risk Reduction Program, which he established several years ago at City of Hope. Due to his strong background in endocrine tumors and thyroid cancer, Dr. Kandeel participates in the development of the national guidelines for the management of neuroendocrine tumors and thyroid cancer.
CA

Associate Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
University of Colorado Denver Health Sciences Program

Type 1 Diabetes
Type 2 Diabetes
Hyperlipidemia
Pre-Diabetes / Diabetes Prevention
Osteoporosis
Thyroid Disease
Obesity

Dr. Leigh Perreault is a physician and clinical researcher at the University of Colorado Denver School of Medicine, Aurora, CO. Her overarching research interest lies in understanding the different pathways by which people develop type 2 diabetes, and developing tailored strategies for diabetes prevention. Research projects to date have yielded valuable information about sex differences in diabetes risk, which lie, in part, in the key metabolic features in people with different types of pre-diabetes (impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and IFG/IGT). Recently, research pursuits have focused on unraveling the pathophysiology underlying isolated IFG Ð a prominent type of pre-diabetes Ð affecting roughly 25 million Americans. Specific environmental pollutants are strongly implicated as causal in IFG, hence proposed projects are aimed at removing these in a research setting to see if normal glucose regulation can be restored. Complimenting her independent research interests, Dr. Perreault works closely with collaborators examining emerging risk factors for diabetes such as sleep restriction, intramuscular lipids and the human microbiome. Dr. Perreault is part of the Diabetes Prevention Program (DPP) and heavily utilizes the Clinical Translational Research Center (CTRC) on campus. Dr. Perreault graduated from the University of Southern California Keck School of Medicine in 1996. She completed a residency in Internal Medicine and fellowship in Endocrinology, Metabolism and Diabetes at the University of Colorado Denver School of Medicine, and is currently board-certified in both. Dr. Perreault has received an Endocrine Fellows Foundation Award, Patient-oriented Career Development Award (K23) from the National Institutes of Health, as well as a Career Development Award from the American Diabetes Association, for her work unraveling the metabolic complexities of pre-diabetes. She works tirelessly on behalf of people at risk for diabetes, both as a volunteer for the American Diabetes Association, a national and internal educator, and directly through clinical care of people with pre-diabetes and diabetes.
CO